DIFFUSIO2N Trademark

Trademark Overview

On Thursday, April 15, 2004, a trademark application was filed for DIFFUSIO2N with the United States Patent and Trademark Office. The USPTO has given the DIFFUSIO2N trademark a serial number of 76586814. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 27, 2008. This trademark is owned by Diffusion Pharmaceuticals LLC. The DIFFUSIO2N trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, drugs that increase tissue oxygenation and drugs that assist with cancer treatment
diffusio2n

General Information

Serial Number76586814
Word MarkDIFFUSIO2N
Filing DateThursday, April 15, 2004
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 27, 2008
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, July 5, 2005

Trademark Statements

Disclaimer with Predetermined TextDIFFUSION
Goods and ServicesPharmaceuticals, namely, drugs that increase tissue oxygenation and drugs that assist with cancer treatment
Pseudo MarkDIFFUSION

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 5, 2004
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDiffusion Pharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCharlottesville, VA 22902
Party NameDiffusion Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCharlottesville, VA 22902

Trademark Events

Event DateEvent Description
Monday, October 27, 2008ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 27, 2008ABANDONMENT - NO USE STATEMENT FILED
Saturday, September 27, 2008DIVISIONAL PROCESSING COMPLETE
Thursday, March 20, 2008DIVISIONAL REQUEST RECEIVED
Thursday, September 25, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 24, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 14, 2008UNDELIVERABLE MAIL - NO ACTION TAKEN
Wednesday, March 26, 2008EXTENSION 5 GRANTED
Monday, March 3, 2008EXTENSION 5 FILED
Thursday, March 20, 2008PAPER RECEIVED
Monday, March 3, 2008PAPER RECEIVED
Monday, September 24, 2007EXTENSION 4 GRANTED
Tuesday, September 4, 2007EXTENSION 4 FILED
Tuesday, September 4, 2007PAPER RECEIVED
Tuesday, May 15, 2007UNDELIVERABLE MAIL - NO ACTION TAKEN
Tuesday, May 1, 2007EXTENSION 3 GRANTED
Friday, February 2, 2007EXTENSION 3 FILED
Friday, February 2, 2007PAPER RECEIVED
Wednesday, September 13, 2006EXTENSION 2 GRANTED
Friday, August 11, 2006EXTENSION 2 FILED
Friday, August 11, 2006PAPER RECEIVED
Friday, December 30, 2005EXTENSION 1 GRANTED
Wednesday, November 30, 2005EXTENSION 1 FILED
Wednesday, November 30, 2005PAPER RECEIVED
Tuesday, September 27, 2005NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 5, 2005PUBLISHED FOR OPPOSITION
Wednesday, June 15, 2005NOTICE OF PUBLICATION
Friday, March 25, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, March 18, 2005ASSIGNED TO LIE
Monday, March 14, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 11, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, March 6, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, March 6, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 19, 2004NON-FINAL ACTION MAILED
Thursday, November 18, 2004NON-FINAL ACTION WRITTEN
Monday, November 8, 2004ASSIGNED TO EXAMINER
Wednesday, May 5, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

diffusio drugs assist cancer oxygenation treatment tissue namely increase pharmaceuticals